ASSEMBLY BIOSCIENCES, INC. Quarterly Return On Equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Assembly Biosciences, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q3 2024.
  • Assembly Biosciences, Inc. Return On Equity for the quarter ending September 30, 2024 was -121 %, a 4.33% decline year-over-year.
  • Assembly Biosciences, Inc. annual Return On Equity for 2023 was -118 %, a 44.1% decline from 2022.
  • Assembly Biosciences, Inc. annual Return On Equity for 2022 was -81.7 %, a 37.2% decline from 2021.
  • Assembly Biosciences, Inc. annual Return On Equity for 2021 was -59.5 %, a 147% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -121 -5.04 -4.33% Jul 1, 2024 Sep 30, 2024
Q2 2024 -122 -16.7 -15.9% Apr 1, 2024 Jun 30, 2024
Q1 2024 -121 -26.8 -28.6% Jan 1, 2024 Mar 31, 2024
Q4 2023 -118 -36 -44.1% Oct 1, 2023 Dec 31, 2023
Q3 2023 -116 -19.8 -20.5% Jul 1, 2023 Sep 30, 2023
Q2 2023 -105 -28.7 -37.6% Apr 1, 2023 Jun 30, 2023
Q1 2023 -93.8 -28.7 -44% Jan 1, 2023 Mar 31, 2023
Q4 2022 -81.7 -22.2 -37.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 -96.6 -50.5 -109% Jul 1, 2022 Sep 30, 2022
Q2 2022 -76.2 -38.4 -102% Apr 1, 2022 Jun 30, 2022
Q1 2022 -65.1 -40.7 -166% Jan 1, 2022 Mar 31, 2022
Q4 2021 -59.5 -35.4 -147% Oct 1, 2021 Dec 31, 2021
Q3 2021 -46.2 -27.4 -146% Jul 1, 2021 Sep 30, 2021
Q2 2021 -37.8 -7.66 -25.4% Apr 1, 2021 Jun 30, 2021
Q1 2021 -24.5 +21 +46.2% Jan 1, 2021 Mar 31, 2021
Q4 2020 -24.1 +25 +50.9% Oct 1, 2020 Dec 31, 2020
Q3 2020 -18.8 +34.1 +64.5% Jul 1, 2020 Sep 30, 2020
Q2 2020 -30.1 +16.2 +34.9% Apr 1, 2020 Jun 30, 2020
Q1 2020 -45.4 +11 +19.5% Jan 1, 2020 Mar 31, 2020
Q4 2019 -49.1 +8.34 +14.5% Oct 1, 2019 Dec 31, 2019
Q3 2019 -52.8 -2.2 -4.35% Jul 1, 2019 Sep 30, 2019
Q2 2019 -46.3 +20 +30.2% Apr 1, 2019 Jun 30, 2019
Q1 2019 -56.5 +0.1 +0.18% Jan 1, 2019 Mar 31, 2019
Q4 2018 -57.5 +2.67 +4.44% Oct 1, 2018 Dec 31, 2018
Q3 2018 -50.6 +31.1 +38% Jul 1, 2018 Sep 30, 2018
Q2 2018 -66.3 +2.49 +3.62% Apr 1, 2018 Jun 30, 2018
Q1 2018 -56.6 -0.75 -1.34% Jan 1, 2018 Mar 31, 2018
Q4 2017 -60.2 -13.5 -29% Oct 1, 2017 Dec 31, 2017
Q3 2017 -81.7 -43 -111% Jul 1, 2017 Sep 30, 2017
Q2 2017 -68.8 -37.6 -120% Apr 1, 2017 Jun 30, 2017
Q1 2017 -55.8 -29.1 -109% Jan 1, 2017 Mar 31, 2017
Q4 2016 -46.6 -23.8 -105% Oct 1, 2016 Dec 31, 2016
Q3 2016 -38.7 -14.2 -57.7% Jul 1, 2016 Sep 30, 2016
Q2 2016 -31.3 +3.41 +9.83% Apr 1, 2016 Jun 30, 2016
Q1 2016 -26.7 +16.2 +37.8% Jan 1, 2016 Mar 31, 2016
Q4 2015 -22.8 +41.3 +64.5% Oct 1, 2015 Dec 31, 2015
Q3 2015 -24.5 +58 +70.3% Jul 1, 2015 Sep 30, 2015
Q2 2015 -34.7 +37.1 +51.7% Apr 1, 2015 Jun 30, 2015
Q1 2015 -42.9 +30.2 +41.4% Jan 1, 2015 Mar 31, 2015
Q4 2014 -64.1 +0.2 +0.31% Oct 1, 2014 Dec 31, 2014
Q3 2014 -82.5 -22.4 -37.3% Jul 1, 2014 Sep 30, 2014
Q2 2014 -71.8 -4.72 -7.03% Apr 1, 2014 Jun 30, 2014
Q1 2014 -73.1 +8.62 +10.5% Jan 1, 2014 Mar 31, 2014
Q4 2013 -64.3 +43.6 +40.4% Oct 1, 2013 Dec 31, 2013
Q3 2013 -60.1 +86.6 +59% Jul 1, 2013 Sep 30, 2013
Q2 2013 -67.1 +48.1 +41.8% Apr 1, 2013 Jun 30, 2013
Q1 2013 -81.7 +47 +36.5% Jan 1, 2013 Mar 31, 2013
Q4 2012 -108 Oct 1, 2012 Dec 31, 2012
Q3 2012 -147 Jul 1, 2012 Sep 30, 2012
Q2 2012 -115 Apr 1, 2012 Jun 30, 2012
Q1 2012 -129 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.